The Meyers Lab is focused on more effectively bridging the gap between the development of optimal therapeutic, prophylactic and diagnostic approaches for infectious diseases (e.g., HIV, viral hepatitis, coronaviruses) and their practical implementation. Positioned at the far end of the translational research process, our work extends beyond the bedside to the study of the processes and factors supporting successful, evidence-based interventions within specific clinical and public health settings. Using mixed-method approaches, our goal is to ensure that emergent clinical and public health interventions are available to practitioners and to potential beneficiaries, to prepare for the rapid and sustained adoption of new biomedical interventions and to maximize health benefits at the population level. To that end, our lab collaborates with clinical sites, community-based organizations and government organizations to implement NIH-funded studies internationally and domestically. Engaging stakeholders at all stages of the research is a critical component of our process, leading to practical study design, and findings that are useful to our partners.
For participants in CoV-SCAN studies: